THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 35 filers reported holding THERAVANCE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,169,000 | +1.3% | 4,748,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $5,101,000 | -1.4% | 4,748,000 | -6.7% | 0.01% | 0.0% |
| Q2 2021 | $5,174,000 | +1.6% | 5,091,000 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $5,094,000 | +35.6% | 5,091,000 | +34.8% | 0.01% | +50.0% |
| Q4 2020 | $3,758,000 | +3.9% | 3,778,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,616,000 | +1.5% | 3,778,000 | +4.7% | 0.00% | -20.0% |
| Q2 2020 | $3,563,000 | -23.7% | 3,610,000 | -28.1% | 0.01% | -28.6% |
| Q1 2020 | $4,670,000 | -7.2% | 5,024,000 | 0.0% | 0.01% | +16.7% |
| Q4 2019 | $5,035,000 | +6.8% | 5,024,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $4,716,000 | -10.5% | 5,024,000 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $5,269,000 | +29.7% | 5,024,000 | +25.5% | 0.01% | +40.0% |
| Q1 2019 | $4,062,000 | -16.2% | 4,004,000 | -10.8% | 0.01% | -28.6% |
| Q4 2018 | $4,849,000 | – | 4,487,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antara Capital LP | 40,888,000 | $41,182,000 | 8.34% |
| Castle Creek Arbitrage, LLC | 3,583,000 | $3,611,000 | 0.83% |
| LINDEN ADVISORS LP | 68,022,000 | $68,478,000 | 0.81% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 35,565,000 | $35,953,000 | 0.70% |
| CSS LLC/IL | 6,234,000 | $6,267,000 | 0.35% |
| AQR Arbitrage LLC | 18,768,000 | $18,903,000 | 0.32% |
| SSI INVESTMENT MANAGEMENT LLC | 3,000,000 | $3,006,000 | 0.20% |
| Wellesley Asset Management | 927 | $934,000 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 19,500,000 | $19,639,000 | 0.03% |
| Daiwa Securities Group Inc. | 2,500,000 | $2,511,000 | 0.02% |